Deep · Tier 2 · Genome + Wearable
Antiaging Labs · Deep Report · Sample · 22 Jun 2026

Client #6, your DNA loaded the dice.
Your blood and your wearable show them rolling.

Genetically cardiometabolic, behaviourally under-recovered · APOE e4 carrier · Early insulin resistance · Central adiposity
Chronological
40
years
Biological (PhenoAge)
42.9
2.9 years older, and movable
Data layers read
3
genome · blood · wearable
Findings reconciled
29
into 3 root causes
"I want my energy and focus back, and I don't want my dad's heart disease."

His two goals are one problem. The same Zone-2, sleep and fat-quality work that lifts the energy also drives down the cardiovascular risk his genome and his father both flagged.

01 · The convergence

Three layers, one verdict.

A single panel can be reassuring. Three panels that agree are a direction. Here the genome, the bloodwork and the wearable all point at the same place.

Genome predicts it

The dice are loaded

APOE e4, genetically high Lp(a), the 9p21 CAD locus and a TCF7L2 diabetes variant. A family of cardiometabolic risk written before he was born.

Blood confirms it

Already surfacing

ApoB 105, Lp(a) 145, HDL 38, hsCRP 2.6, HOMA-IR 2.9, and early NAFLD enzymes. The predisposition is no longer theoretical.

Wearable shows the driver

Why it is rolling

HRV down 22%, resting HR up 4 bpm, 11% deep sleep on 6 hours, almost no Zone-2. Stress-rich and exercise-poor, every day.

02 · The Living Biological Twin

A live model of how each system is aging.

Not a single number. Six systems, each with its own aging speed, updating as your wearable streams in. This is the model you open every morning.

Brain watch Vascular aging fast Metabolic aging fast Autonomic under strain Liver watch Hormonal watch
Live from Whoop
42.9
biological age
2.9 yrs over chronological 40

Streaming now

HRV (RMSSD)32 ms
Resting HR62 bpm
Deep sleep11%
VO2max est.38
Load (ACWR)0.58

Each marker maps to a system on the body. Vascular and metabolic are aging fastest, the autonomic system is under strain. None of it is fixed: every system here has a lever in the protocol below.

03 · The Genomic Filter

Your DNA, turned into instructions.

Sequenced once, read into every protocol we ever build for you. Tap any variant to see exactly how it changed your plan.

Risk · lifetime predisposition
APOEe3/e4

One e4 copy raises lifetime cardiovascular and Alzheimer's risk, and makes your LDL and ApoB respond more strongly to saturated fat. It is also one of the most lifestyle-responsive risk genes there is.

Your ApoB target is set to under 70 (not the usual 80 to 100), the fat profile goes Mediterranean, and Zone-2 plus deep sleep become brain-health levers, not just heart.
A note on this result. e4 is a probability shift, not a diagnosis or a destiny. We are happy to set up a genetic-counseling conversation if you would like one. It is entirely your choice.
LPAelevated · 145 nmol/L Ancestry note

Genetically elevated Lp(a), confirmed in your blood. A lifelong cardiovascular amplifier that lifestyle cannot move. Common and under-tested, and a frequent hidden driver of early heart disease.

Because Lp(a) itself will not move, we drive down every other ApoB-mediated risk instead, and flag first-degree family Lp(a) screening, since it is inherited.
9p21 (CDKN2B-AS1)CC

Two copies at the most-replicated coronary-artery-disease locus, acting independent of your lipids.

Adds weight to early, aggressive ApoB control and an earlier clinician conversation. Stacked with APOE and Lp(a), the cardiovascular lever leads the whole plan.
TCF7L2CT Ancestry note

One copy of the strongest common type-2-diabetes variant, which lowers your insulin-secretion reserve.

Your early insulin resistance (HOMA-IR 2.9) matters more for you than for the average 40-year-old, so the metabolic lever is raised and we retest glucose and insulin earlier.
Pharmacogenomics · how you handle drugs and stimulants
CYP1A2CC · slow

You clear caffeine slowly, so an afternoon coffee measurably hurts that night's sleep and the next day's HRV.

Caffeine cutoff is 10:00 and two cups maximum. Your own Whoop proves it: HRV crashes on the nights you have a late espresso (see Autopilot).
SLCO1B1TC

Intermediate statin-transporter function, which modestly raises statin-myopathy risk.

If your physician starts a statin for the lipid picture, this note favors a non-simvastatin choice or a lower dose. We never prescribe. We hand the prescriber the data.
CYP2C19GA · intermediate Ancestry note

Intermediate metabolizer. Dormant for now, relevant only if clopidogrel or a PPI is ever prescribed.

No action today. The note sits in your record so a future prescriber gets it automatically.
Methylation & lifestyle
MTHFR C677TCT

About 65% enzyme activity. With your homocysteine at 12.5, the active B-vitamin forms are the right choice.

Your B-vitamin is methylfolate plus methyl-B12, not folic acid. A small, targeted switch, not a stack. Gated on the measured homocysteine, never on the gene alone.
COMT + BDNFVal/Met · Met

Dopamine-clearance and BDNF traits that favor steady aerobic down-regulation over high-stimulant strategies.

Your stress lever leans on breathwork and Zone-2 (which you need anyway), and aerobic exercise plus sleep are doubly worthwhile for you.
04 · Autopilot Protocol Sync

From telemetry flux to protocol patch.

The plan is not a PDF you forget. It reads your wearable every morning and adjusts the day, with your genome and bloodwork as context.

Antiaging LabsAutopilot
Tue · 07:08
HRV 24 ms (down 41% vs baseline) · deep sleep 38 min
Espresso logged 16:10. You clear caffeine slowly (CYP1A2), so it was still active at bedtime. Sleep onset ran 47 min late.
Skip the morning espresso, it will deepen the debt. 20-min Zone-2 walk in daylight to lift HRV. Hold today's heavy session to tomorrow.
Sun · 07:30
7-day HRV trend down 18% · resting HR up 4 bpm
Strain has outrun recovery this week, travel plus two late dinners.
Today is a true recovery day, no training. Protect 7.5 hours tonight. Magnesium at 21:30, phone out of the bedroom.
Mon · 06:55
HRV 47 ms (up 15%) · deep sleep 1h12m
Caffeine cutoff held at 10:00 yesterday and you were in bed by 23:15. It shows.
Green light. This is your day for the Zone-2 plus lower-body strength session. Same caffeine rule today.
Thu · 07:20
Resting HR 69 (up 11) · sleep 4h35m
Red-eye to Singapore, sleep debt plus dehydration.
No training today. Two extra glasses of water before noon, 15-min daylight on landing, caffeine before 10:00 local only.

A closed loop, not a checklist

Every intercept is the join of three things: a real telemetry event from your wearable, the genomic or biochemical reason behind it, and a specific patch for the day. It is advisory, never a medical instruction, and it learns which behaviours move your numbers.

Telemetry Reason Patch
What it caught this quarter
x7HRV crashes traced to a post-3pm coffee, your slow-caffeine genotype made visible
x4Travel nights flagged early, training pulled back before the body forced it
x3Alcohol-suppressed REM caught, next-day load adjusted down

The crashes cluster on the same nights: late caffeine, alcohol, travel. The loop turns that into fewer bad mornings, and the trend back into the Twin above.

05 · Biological age

How fast you are aging, by the blood.

PhenoAge is a validated estimate from nine blood markers plus your age, trained on long-term mortality data (Levine 2018). Not a diagnosis. A snapshot, and a movable one.

42.9
2.9 years older than your calendar age. The opportunity, not a sentence.
Day 1: 42.9  ·  Day 30 est: 42.6  ·  Day 90 target: 41.8

PhenoAge moves only modestly here, because its nine inputs capture just part of your risk. The big wins (ApoB, HOMA-IR, HDL, HRV, VO2max, liver enzymes) sit outside the PhenoAge markers, which is exactly why the Deep panel, the genome and the wearable matter.

Albumin4.4 g/dL
Creatinine1.0 mg/dL
Glucose (fasting)100 mg/dL
hsCRP2.6 mg/L
Lymphocyte %28%
MCV89 fL
RDW13.9%
Alkaline phosphatase82 U/L
White cell count6.9 K/uL
06 · Biomarker analysis

The advanced panel, read against your genome.

The markers that matter most, grouped by system, each cross-referenced to the DNA and telemetry that explain it.

Cardiovascular

the lead system

An atherogenic lipid load, amplified by three genetic risk factors and a strong family history. Every number here points the same way, and it is the system the whole protocol leads with.

ApoBthe particle count that actually drives plaque
105 mg/dL
optimal <70 (e4-set)
OFF-TARGET
LDL cholesterol
142 mg/dL
optimal <100
OFF-TARGET
HDL cholesterol
38 mg/dL
optimal >45
OFF-TARGET
Non-HDL cholesterol
161 mg/dL
optimal <130
OFF-TARGET
Total cholesterol
199 mg/dL
context only
WATCH
Triglycerides
165 mg/dL
optimal <100
OFF-TARGET
Lp(a)genetic, lifelong, lifestyle-fixed
145 nmol/L
optimal <75
REFER
ApoA1protective particle
120 mg/dL
optimal >140
WATCH
Genome + family. APOE e4 (R-GEN-APOE-01) tightens your ApoB target to under 70 and makes the saturated-fat swap genuinely worth it for you. Genetically high Lp(a) (R-GEN-LPA-01) plus the 9p21 CAD locus stack on top, and your father's heart attack at 58 makes it concrete rather than abstract. Lp(a) itself will not move, so the strategy is to crush every other particle hard.

Insulin & metabolic

reversible now

Early, reversible insulin resistance with impaired fasting glucose, on a genetic diabetes background. The most fixable thing in the report.

HOMA-IRinsulin resistance index
2.91
optimal <1.5
OFF-TARGET
Fasting insulin
11.8 uIU/mL
optimal <7
OFF-TARGET
Fasting glucose
100 mg/dL
optimal 75-90
WATCH
HbA1c3-month average glucose
5.6 %
optimal <5.4
WATCH
Uric acid
6.9 mg/dL
optimal <6.0
WATCH
Genome + wearable. The TCF7L2 variant (R-GEN-TCF7L2-01) lowers your insulin-secretion reserve, so this matters more for you than for the average 40-year-old. The Whoop confirms the driver: almost no Zone-2 (ACWR 0.58), VO2max drifting, ~5,000 steps a day. Muscle is your glucose sink, and you are not using it.

Inflammation & methylation

hsCRPsystemic inflammation, cardiovascular-weighted
2.6 mg/L
optimal <1.0
OFF-TARGET
Homocysteine
12.5 umol/L
optimal <9
WATCH
Genome. hsCRP at 2.6 sits in the intermediate cardiovascular-risk band and adds to the lipid story. Your MTHFR C677T (R-GEN-MTHFR-01) with this homocysteine switches your B-vitamin to methylfolate plus methyl-B12, not folic acid, a small targeted switch gated on the measured value, not the gene alone.

Liver

early NAFLD, no fibrosis
ALT
48 U/L
optimal <30
WATCH
GGT
62 U/L
optimal <30
WATCH
AST
30 U/L
optimal <30
WATCH
FIB-4fibrosis screen
0.69
<1.30 reassuring
OPTIMAL
Read together. ALT and GGT up with a normal FIB-4 is early fatty liver (steatosis), not fibrosis, driven by visceral fat, insulin resistance and weekly alcohol. It moves with the same levers as the metabolic panel, no separate workup needed now.

Vitamins & minerals

Vitamin D (25-OH)
24 ng/mL
optimal 40-60
WATCH
Vitamin B12
410 pg/mL
optimal >400
OPTIMAL
Folate
8.0 ng/mL
optimal >7
OPTIMAL
Ferritinhigh-normal, tracks inflammation here
165 ng/mL
30-300
IN RANGE
Magnesium
2.0 mg/dL
optimal >2.0
OPTIMAL
One clear gap. Vitamin D is insufficient and worth correcting (it supports metabolic health, mood and the immune system). Folate and B12 are fine, but with MTHFR we still use the methylated forms so the homocysteine actually moves.

Hormonal & thyroid

Testosterone (total)
420 ng/dL
optimal >600
WATCH
AM cortisol
18 ug/dL
upper-normal
WATCH
TSH
2.1 mIU/L
optimal 0.5-2.5
OPTIMAL
Free T3 / Free T4
3.1 / 1.3
in range
OPTIMAL
Don't chase this directly. Testosterone below optimal with upper-normal cortisol is the signature of under-recovery and central fat, not a primary endocrine problem. Fix sleep, stress and visceral fat and it follows. We do not jump to testosterone therapy, and thyroid is genuinely fine.

Kidney, blood & what is already strong

protect these
eGFR
95 mL/min
>90
OPTIMAL
Creatinine
1.0 mg/dL
in range
OPTIMAL
Hemoglobin
15.2 g/dL
13-17
OPTIMAL
MCV / RDW
89 / 13.9
in range
OPTIMAL
WBC / Platelets
6.9 / 250
in range
OPTIMAL
Good foundations. Kidneys, red cells, white cells and thyroid are all healthy. That matters, it means the work can focus entirely on the cardiometabolic and recovery story without a competing problem to manage.

What the ratios say

the derived picture

Single markers can mislead. The ratios below are often the earliest and clearest signal, especially for South-Asian cardiometabolic risk.

HOMA-IR2.91
Insulin resistance. Above 1.5 means your body is working harder to keep glucose normal. The hinge between the genome and the heart risk.
TG : HDL4.34
A strong insulin-resistance and small-dense-LDL proxy. Optimal is under 2. Yours is more than double.
AIP0.64
Atherogenic Index of Plasma, a powerful cardiovascular-event predictor in Indian cohorts. Above 0.21 is high risk.
ApoB : ApoA10.88
The cleanest single ratio of harmful to protective particles. Optimal is under 0.5. The core of the lipid problem.
Castelli I (TC/HDL)5.24
Cardiac risk index. Optimal is under 3.5. Driven by the low HDL as much as the high LDL.
Castelli II (LDL/HDL)3.74
Optimal is under 3. Confirms the same atherogenic pattern from a second angle.
NLR2.07
Neutrophil-to-lymphocyte ratio, an inflammation and stress proxy. Under 3 is fine, so this part is reassuring.
FIB-40.69
Liver-fibrosis screen. Under 1.30 is reassuring, so the fatty-liver enzymes are early-stage, not scarring.
07 · Root causes

Twenty-nine findings, three root causes.

We do not hand you a checklist of fifteen fixes. We trace the findings back to the few drivers that explain them, and attack there.

RC-1 · Cardiometabolic genetic load

genome + blood + family agree

APOE e4, genetically high Lp(a), the 9p21 CAD locus and TCF7L2, made real by a father's heart attack at 58. The genome cannot be changed. Its expression, ApoB, can be driven down hard.

explains: Lp(a) 145 · ApoB 105 · LDL 142 · HDL 38 · AIP 0.64 · CAD/T2D predisposition
Attack via: ApoB under 70 through Zone-2, soluble fiber, fat-quality swaps and omega-3, plus a lipidology conversation about a statin (SLCO1B1-informed) and family Lp(a) screening.

RC-2 · Chronic under-recovery

blood + wearable + intake agree

A founder in a fundraise: 6 hours of sleep, phone in bed, four coffees (two late) on a slow-caffeine background, no Zone-2, frequent red-eyes. The Whoop shows the autonomic cost in real time.

explains: cortisol 18 · HRV 41 to 32 · RHR 58 to 62 · testosterone 420 · hsCRP 2.6 · deep sleep 11%
Attack via: protect sleep, caffeine cutoff at 10:00, a Zone-2 base, one true recovery day and daily breathwork.

RC-3 · Early insulin resistance and ectopic fat

blood + wearable + intake agree

Sedentary, refined-carb-heavy ordered-in meals, late dinners and weekly alcohol, on a TCF7L2 background that lowers his reserve. The modifiable hinge between the genome and the heart risk.

explains: HOMA-IR 2.91 · glucose 100 · TG 165 · ALT 48 / GGT 62 · waist 96 cm
Attack via: Zone-2 plus resistance training, protein and soluble fiber, fewer late dinners and drinks. Visceral-fat loss lowers ApoB, TG and liver enzymes and raises HDL and testosterone at once.
08 · The intake, in his words

Your blood said what. Your answers said why.

We do not personalize from blood and DNA alone. A fifteen-section intake is why this plan looks like yours, built around travel and a fundraise, and not a template. The starred sections are the ones that changed the protocol most.

01 · Identity & goals
OccupationFounder and CEO, B2B SaaS, ~70 people, currently mid-fundraise.
What do you want from this?"I want my energy and focus back, and I don't want my dad's heart disease."
02 · Family history ★
CardiovascularFather had a heart attack at 58, now on a statin. Paternal uncle had a bypass in his 60s.
DiabetesMother, type 2, diagnosed at 55. Maternal grandmother lived to 92.
03 · Body & medical
Build84 kg, 178 cm, BMI 26.5, waist 96 cm, the central, lower-BMI pattern that often shows up even at a normal-ish BMI.
Medications / conditionsNone regular. Blood pressure flagged at the last visit (138/86, untreated). No known allergies.
04 · Diet, the pattern ★
How do you eat?Eats out or orders in ~6x/week on the founder schedule. Red meat 2x, chicken 4x, 1-2 veg servings/day, fried food ~3x/week, dinner often after 9pm.
05 · Drinks, caffeine & alcohol ★
Caffeine4 coffees a day, two of them after 3pm in crunch weeks, on a slow-caffeine genotype.
Alcohol3-4 drinks a week, clustered at investor and team dinners.
06 · Movement & training ★
What do you do?Gym about once a week when travel allows, occasional weekend badminton. Essentially no steady cardio. "It's the first thing that gets dropped when work spikes."
07 · Sleep & recovery ★
Your nightsIn bed 00:30-01:00, up at 06:45, ~6 hours. Phone in bed, mind racing about work. "I'm tired all day and wired all night."
08 · Stress, mood & mind ★
Stress load8 out of 10. "Always-on. The company is in a fundraise. I can't switch off." Tried meditation apps, nothing stuck, no breathwork.
09 · Energy & drive
Through the dayDaily ~3pm crash, usually fixed with another coffee. Poor morning energy without caffeine, libido lower than a few years ago.
10 · Environment, data & constraints ★
TravelBangalore-based, 2-3 trips a month, frequent red-eyes to Delhi and South-East Asia.
Data sharedWhole-genome sequencing and 14 months of Whoop data. Biggest obstacle: anything that needs a fixed daily slot tends to fail.
09 · The protocol

Five levers, tuned to you.

Genome-informed and wearable-driven, built around a founder's travel and a fundraise. The goal of 90 days is not to do everything, it is to install six habits deeply enough that they stop needing willpower. Three pillars sit underneath the five levers.

Pillar 1

Drive ApoB under 70

Zone-2 cardio 150 min a week, soluble fiber 10g a day, saturated to unsaturated fat swap, omega-3, and the physician conversation about a statin. One change set, your biggest genetic risk.

Targets by Day 90: ApoB 105 to under 85 (toward under 70 with pharmacotherapy) · LDL 142 to under 115 · HDL 38 to 44+ · AIP 0.64 to 0.4
Pillar 2

Recover as hard as he works

Sleep 6 to 7.5 hours, caffeine cutoff 10:00 (slow metabolizer), one true recovery day, daily breathwork. The lever behind the energy and focus he came in for.

Targets by Day 90: HRV 32 back toward 41 · RHR 62 to 58 · cortisol 18 to 14 · deep sleep 11% to 16% · testosterone 420 to 480+
Pillar 3

Reverse the early insulin resistance

Zone-2 plus two resistance sessions, protein-forward lower-glycemic meals that survive travel, fewer late dinners and drinks. Visceral fat is the common denominator.

Targets by Day 90: HOMA-IR 2.91 to under 2.0 · glucose 100 to under 95 · TG 165 to under 120 · ALT 48 to under 35 · waist 96 to under 92
Lever 01 · Training Lead

Build the aerobic base you never had

Right now you do under 30 minutes of structured aerobic work a week while sitting most of the day (ACWR 0.58, VO2max drifting down, ~5,000 steps). That single gap is why your HDL is low, your insulin is creeping, and your energy is gone. Zone-2 is the top lever for all three at once, and for an APOE e4 carrier it is a brain lever too. You are exercise-poor, not over-trained, so the job is to add a base, built so it survives constant travel.

Weekly structure

A sample week

The 12-week progression

Your ACTN3 is a mixed power/endurance profile, a tie-breaker only, the Zone-2 priority stands. Your BDNF Met variant means aerobic work and sleep are doubly worthwhile for the brain. Evidence: Zone-2 for VO2max, HDL and insulin sensitivity [E1]; resistance for glucose disposal [E1]; aerobic fitness and cognition [E2].

Lever 02 · Recovery & Sleep Lead

The cheapest win in this whole report

You sleep about six hours with only 11% deep sleep, your HRV is falling and your resting HR is rising. Short, shallow sleep sits underneath your insulin resistance, your testosterone, your HRV and your focus all at once. Moving lights-out from ~00:45 to 23:00 buys roughly 1.5 hours at almost zero willpower cost, and it is the keystone the rest of the plan leans on.

The wind-down

Caffeine, by your genotype

Recovery and travel

Evidence: sleep extension for insulin sensitivity, testosterone and recovery [E1]; morning light for circadian alignment [E2]; caffeine timing and sleep architecture [E1].

Lever 03 · Nutrition Lead

Two structural moves, built for a founder who eats out

You order in or eat out about six times a week and you travel constantly, so severity is the wrong tool, it will not survive a single hard week. We change exactly two things: shift fat quality (Mediterranean-leaning, which your APOE e4 makes genuinely worth it), and add soluble fibre and protein. Both lower ApoB and improve insulin sensitivity at the same time.

Daily targets

Protein
~140 g
Fibre
35 g (10 g soluble)
Added sugar
minimal
Alcohol
≤ 2 drinks/week
Dinner
earlier when home
Fat profile
Mediterranean

Fat quality, per your APOE e4

Fibre and protein

Ordering rules for the road

A sample week (foods you already eat)

Emphasize: olive and mustard oil, fatty fish, dal, oats and chia, psyllium, eggs and dahi, berries and guava, leafy greens (folate). Deprioritize: ghee and butter, fried orders, rice and naan in volume, dessert, sugary drinks, alcohol beyond two a week. Evidence: soluble fibre for ApoB and LDL [E1]; saturated-to-unsaturated fat swap, sharper for e4 [E1]; protein for satiety and glycemic control [E1].

Lever 04 · Supplements

Six targeted items, not a twenty-bottle stack

You currently take almost nothing consistently, so this is about adding a small, evidence-led set, each tied to a finding, not building a shelf. The one big lever, a statin, stays a physician decision.

Omega-32 g EPA+DHA
with a meal
Lowers triglycerides and supports ApoB, and is a brain lever for your e4. Algal version if you want to avoid fish entirely.ADD
Psyllium husk1 tbsp
before a meal
The highest-leverage, vegetable-light soluble fibre for ApoB and LDL. Take with a full glass of water.ADD
Methylfolate +
methyl-B12
400-800 mcg
morning
Chosen by your MTHFR C677T result and the measured homocysteine of 12.5. Active forms, not folic acid.ADD
Vitamin D3 + K22,000 IU + 100 mcg
with breakfast
Your 25-OH-D is 24 ng/mL. Repletes toward 40-60; K2 directs calcium to bone, not arteries. Retest at week 12.ADD
Magnesium glycinate300 mg
evening
Supports sleep depth and recovery, the glycinate form is gentle and well absorbed.ADD
Creatine monohydrate3-5 g
any time
Supports training output and cognition, your stated focus goal. Among the most evidence-backed supplements there is.ADD
Statin / lipid therapyphysician
decision
Likely warranted given ApoB 105 + Lp(a) 145 + APOE e4 + family history. Not ours to start.PHYSICIAN

Pharmacogenomic note (SLCO1B1, TC): if your physician does start a statin, this variant favors a non-simvastatin agent or a lower dose to reduce muscle-side-effect risk. Carry that note to the prescriber. The engine never prescribes or doses a medication.

Lever 05 · Mind & Wellness

Down-regulate a real, situational stress load

Your stress sits at 8 out of 10 in the middle of a fundraise, and you do no breathwork. This is situational and honest, not a supplement problem, and your COMT Val/Met profile responds best to steady, low-stimulant down-regulation rather than more intensity.

A supporting domain, paired with Recovery. Evidence: slow breathing for acute stress and HRV [E2]; behavioural activation through exercise for mood [E2].

10 · The 90-day plan

A cadence, not a sprint.

More than six new habits at once and adherence collapses, even for a disciplined operator. They come in pairs, with a coach check-in at each step and the Whoop giving live feedback between calls.

Weeks 1-2
Foundation. Lights-out 23:00 with the phone out of the bedroom. Caffeine cutoff 10:00.
Coach, Day 14: Is the bedtime holding against late work? Is the late coffee gone, and is the Whoop HRV responding? Book the lipid appointment.
Weeks 3-6
Build. 3 Zone-2 sessions a week plus 8k steps. Psyllium and omega-3 daily, smarter ordering.
Coach, Day 28 + 42: Is energy returning? Did the statin conversation happen (SLCO1B1 note carried)? Are the food swaps surviving travel?
Weeks 7-10
Deepen. Add 2 resistance sessions and the first VO2max intervals. 10 min daily breathwork, drinks to two a week.
Coach, Day 56 + 70: Is the afternoon crash gone? VO2max trend on the Whoop? Statin started and tolerated?
Weeks 11-13
Retest prep. Hold all six habits. No heavy training 48 hours before the Day-90 draw, same lab, same morning slot.
Coach, Day 84 + 90: Lock the retest so the ApoB, HOMA-IR and HRV deltas are real. Confirm physician outcomes.
11 · The retest plan

Measured, not assumed.

Adherence is the only variable we cannot control for you. The deltas below are realistic at 80%+ on the six-habit stack. The Day-90 draw uses the same lab, the same morning slot and a 12-hour fast, so the change is real and not noise.

Day 30 · subjective + wearable
  • Energy and the afternoon crash easing
  • Whoop HRV trend turning up, resting HR starting to fall
  • Deep sleep climbing as the caffeine cutoff and bedtime land
Day 60 · the first blood look
  • Lipid panel: ApoB falling, faster if a statin started; HDL beginning to rise
  • Fasting glucose + insulin: HOMA-IR drifting down
  • A checkpoint, not the verdict, to confirm direction
Day 90 · the full panel
  • Priority remeasures: ApoB, LDL, HDL, non-HDL, TG, HOMA-IR, glucose, HbA1c, hsCRP, homocysteine, ALT, GGT, testosterone, vitamin D
  • Targets: ApoB 105 → under 85 (toward 70 on a statin), HOMA-IR 2.9 → under 2.0, TG 165 → under 120, HDL 38 → 44+
  • Add-ons worth it now: ApoB particle / LDL-P, omega-3 index
Week 12 · targeted
  • Vitamin D recheck, expected into the 40-60 ng/mL range on 2,000 IU/day
  • Homocysteine, to confirm the methylated B forms moved it under 9
  • Lp(a) and APOE do not change, they are genetic, set once
12 · Take these to a physician

Three conversations to have with a doctor

Primary care to Lipidology / Cardiology

ApoB 105, LDL 142, Lp(a) 145, APOE e4 and 9p21, with a father's MI at 58. Discuss aggressive ApoB lowering, likely a statin. SLCO1B1 (TC) favors a non-simvastatin agent or lower dose. First-degree family Lp(a) screening.

Genetic counseling (offered, optional)

A conversation about what APOE e4 does and does not mean. It is a modifiable probability shift, not a diagnosis. Entirely his choice.

Primary care

Untreated blood pressure (138/86), early NAFLD enzymes and impaired fasting glucose. Confirm BP with home readings, baseline review. FIB-4 of 0.69 means no fibrosis workup is needed now.

13 · Deliberately not touching

Three things we are leaving alone.

A good protocol is as much about restraint as action. These are the easy mistakes we are choosing not to make.

  1. No testosterone therapy. Your 420 is downstream of six-hour sleep, an 8/10 stress load and central fat. Fix those roots and it recovers on its own. Starting hormones now would mask the real cause.
  2. No crash diet. You travel constantly and eat out six times a week. A rigid plan would collapse on the first hard trip. Portability and two structural swaps beat severity that does not last.
  3. No twenty-bottle supplement stack. Six targeted items, each tied to a finding, plus a physician-decided statin. More bottles is not more health, it is just more to abandon.

Important notes

This is an illustrative sample. Client #6 is a composite Deep-tier profile, anonymized and built to show what the genome and wearable layers add to a report. It is not a real named customer and contains no before-and-after outcome claims. It is a Day-0 baseline and plan.

This report is not a medical diagnosis. It is an evidence-based interpretation of a blood panel, a DNA export, wearable telemetry and lifestyle inputs, designed to inform a 90-day program. It does not replace a licensed physician.

Genomics here is research-grade, not diagnostic. Single common variants carry modest effect sizes. A genotype is a probability shift, never a destiny, and never overrides an observed biomarker trend. APOE e4 is disclosed factually with the offer of genetic counseling. Polygenic estimates are largely European-trained and interpreted with South-Asian context where it applies.

Antiaging Labs is a biomarker-moving and healthspan-optimization program. We do not claim to extend lifespan, reverse aging, or cure disease. We work to move biomarkers in directions associated with better long-term health outcomes per current scientific evidence, and we re-test to show what actually moved.

Data and privacy. Blood results, genome, wearable data and this report are personal health data covered by the Digital Personal Data Protection Act, 2023 (India). The raw genome file is never stored in the report. We do not share identified health data with employers, insurers or advertisers.

Deep sample · generated 22 Jun 2026
Rulebook v0.3.0-deep · PhenoAge v2018
Genome + blood + wearable · Bengaluru, India